View details of this raise on Seedstage

New York, NY

Developing AI-powered software to improve ultrasound cancer diagnostics.

• AI-Powered Diagnostics: Koios Medical uses AI to enhance the accuracy of ultrasound cancer diagnostics.
• FDA-Cleared Technology: The company’s software is FDA-cleared and eligible for insurance reimbursement.
• Global Partnerships: Koios collaborates with GE Healthcare and Philips to integrate its technology into existing systems.
• Market Expansion: Koios is positioned to capture significant market share in the growing AI medical imaging sector.
• Improved Patient Outcomes: The technology helps reduce false positives and unnecessary biopsies, improving patient care.

Koios Medical is advancing the field of medical imaging with its AI-powered software designed to enhance the accuracy of ultrasound diagnostics. The company is expanding its reach by integrating its SmartUltrasound technology into existing systems used by healthcare providers worldwide. This technology assists physicians in detecting breast and thyroid cancers earlier and more accurately, reducing the incidence of false positives and unnecessary biopsies. Koios Medical’s software is FDA-cleared and eligible for insurance reimbursement, which encourages its adoption across hospitals and clinics.

The company collaborates with major industry players such as GE Healthcare and Philips, embedding its technology directly into ultrasound scanners and other medical imaging systems. Koios Medical’s AI algorithms are trained on millions of biopsy-confirmed images, providing a data-driven assessment that supports physicians in making informed diagnostic decisions. As the demand for AI in medical imaging grows, Koios Medical is positioned to capture significant market share, driven by its partnerships and the increasing recognition of its technology’s value in improving diagnostic accuracy and efficiency.

Company Info

Koios Medical develops AI-powered software for enhanced ultrasound cancer diagnostics, improving accuracy and efficiency in medical imaging.

Koios Medical specializes in developing AI-powered software for ultrasound cancer diagnostics, focusing on breast and thyroid cancers. Their SmartUltrasound™ technology is FDA-cleared and integrates seamlessly with existing medical imaging systems, providing physicians with data-driven assessments that enhance diagnostic accuracy and efficiency. The software is designed to reduce false positives and streamline diagnostic workflows, offering significant time savings and improved patient outcomes.

Koios Medical’s technology is widely adopted, with installations in over 1,000 hospitals and clinics across more than 30 countries. The company partners with major industry players like GE Healthcare and Philips, ensuring broad accessibility and integration. By leveraging advanced computer vision AI, Koios aims to transform ultrasound from a variable imaging tool into a consistent and reliable diagnostic resource, ultimately improving the standard of care in medical imaging.